TFF1 and gastric cancer: Given the higher expression of TFF1 in circulating neoplastic cells, we speculate that TFF1 can be detected in the serum, and, therefore, might be applicable in clinical practice as a non-invasive biomarker for the screening of gastric cancer progression.